|
|
|
|
|
|
|
|
|
THE ZANDU
PHARMACEUTICAL WORKS LTD. |
|
|
|
|||
|
Regd. Office : 70, |
|
|
||||
|
|
|
|
|
|
|
|
|
UNAUDITED FINANCIAL
RESULTS (PROVISIONAL) FOR THE QUARTER |
|
|||||
|
ENDED 30TH JUNE, 2006 |
|
(Figures
in Lakhs) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year |
Year |
Financial year |
|
|
|
|
|
ended |
ended |
ended |
|
|
|
|
|
30th June, 2006 |
30th June, 2005 |
31st March, 2006 |
|
|
|
|
|
(Unaudited) |
(Unaudited) |
(Unaudited) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Sales |
2466.68 |
2237.70 |
12994.56 |
|
|
|
|
Other
Income |
54.32 |
59.23 |
328.31 |
|
|
|
|
Total
Income |
2521.00 |
2296.93 |
13322.87 |
|
|
|
|
Total
Expenditure |
|
|
|
|
|
|
|
a)
(Increase) /decrease in stock in trade. |
(123.62) |
57.08 |
160.48 |
|
|
|
|
b)
Consumption of materials. |
814.20 |
606.57 |
3809.65 |
|
|
|
|
c) Excise
Duty |
324.64 |
223.41 |
1543.67 |
|
|
|
|
d) Staff
Cost |
303.36 |
282.14 |
1215.99 |
|
|
|
|
e)
Advertisement and Sales Promotion |
212.77 |
274.40 |
1863.73 |
|
|
|
|
f) Other
expenditure |
571.25 |
553.60 |
2523.70 |
|
|
|
|
Interest |
11.17 |
10.39 |
40.84 |
|
|
|
|
Depreciation |
76.06 |
76.84 |
342.08 |
|
|
|
|
|
|
|
|
|
|
|
|
Profit
before Tax |
331.17 |
212.50 |
1822.73 |
|
|
|
|
|
|
|
|
|
|
|
|
Provision
for Taxation |
|
|
|
|
|
|
|
-- Current Tax |
105.00 |
46.54 |
531.70 |
|
|
|
|
-- Deferred Tax |
6.20 |
9.46 |
12.03 |
|
|
|
|
-- Fringe Benefit Tax |
6.30 |
4.84 |
30.09 |
|
|
|
|
|
|
|
|
|
|
|
|
Profit
after Tax |
213.67 |
151.66 |
1248.91 |
|
|
|
|
|
|
|
|
|
|
|
|
Paid-up
equity share capital |
604.80 |
604.80 |
604.80 |
|
|
|
|
(Face
value Rs.100/-) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reserves
excluding revaluation reserves |
|
|
|
|
|
|
|
(as per
balance sheet) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
& Diluted EPS for the period (Rs) |
35.33 |
25.08 |
206.50 |
|
|
|
|
Aggregate
of non-promoter Shareholding |
|
|
|
|
|
|
|
(a)
Number of Shares |
351661 |
|
327512 |
|
|
|
|
(b)
Percentage of Shareholding |
58.15% |
|
54.15% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Note : |
|
|
|
|
|
|
|
1. The above results were reviewed by the
Audit Committee and were thereafter taken on record by the Board of Directors |
||||||
|
in their Meeting held on 28 th July, 2006 |
|
|
|
|
|
|
|
2. The Company is in pharmaceutical business
and considering the organisation structure of the
company and its internal financial |
||||||
|
reporting,the
company has only one reportable segment as per Accounting Standard on Segment
Reporting (AS - 17). |
||||||
|
3. The Company has investments aggregating to
Rs 14.50 lakhs in the
equity shares of Zandu Chemicals Limited, a company |
||||||
|
promoted by the Company, and has also
given loans / advances to the said company aggregating to Rs
355.34 lakhs, |
||||||
|
which are
outstanding as at 30th June, 2006. The investee
company's accumulated losses have exceeded its networth
and |
||||||
|
as informed the said company has as
required by law referred the matter to Board for Industrial and Financial
Reconstruction |
||||||
|
(BIFR) and the said company is hopeful
of positive outcome.Accordingly,on that basis no
provision is considered necessary |
||||||
|
by the management towards the
diminution in the value of investments considered temporary and loans and
advances |
||||||
|
considered
good of recovery. This is a matter of qualification by the statutory
auditors. |
|
|
||||
|
4. There were no complaints from investors
outstanding at the beginning of the quarter. The Company has received two |
||||||
|
complaints
from the investors during the quarter and all the complaints were
disposed off during the quarter. |
||||||
|
There were no complaints lying
unresolved at the end of the quarter. |
|
|
|
|||
|
5. Previous period figures have been regrouped wherever
necessary. |
|
|
|
|||
|
|
|
|
|
|
|
|
|
|
For The Zandu
Pharmaceutical Works Ltd. |
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Place :
Mumbai |
|
(Girish
Parikh) |
|
|
|
|
|
Date :
28th July, 2006 |
|
Managing Director |
|
|
|
|